New implant could help people stay off opioids for months
NCT ID NCT05382091
First seen Feb 24, 2026 · Last updated May 07, 2026 · Updated 5 times
Summary
This study tests the safety of a long-acting naltrexone implant (OLANI) in 250 adults with opioid use disorder who want to prevent relapse. The implant releases medication over several months to block the effects of opioids, helping patients focus on recovery. Participants will receive up to four implants over about a year, and researchers will monitor side effects and opioid overdose events.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.